ArticleCancer drug resistance (Alhambra, Calif.)2022

Ovarian cancer recurrence: is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? : a clinical perspective.

Peter G RosePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.